PMV Pharmaceuticals Reports Third Quarter 2024 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Marvell shares jump after giving Google warrants amid custom chip deal
Oppenheimer Upgrades PMV Pharmaceuticals Inc. (PMVP) to Outperform
November 8, 2024 6:04 AM ESTOppenheimer analyst Jeff Jones upgraded PMV Pharmaceuticals Inc. (NASDAQ: PMVP) from Perform to Outperform with a price target of $6.00.
The analyst comments "On Thursday, PMV Pharmaceuticals reported 3Q results and provided a business update. The Phase 2/pivotal monotherapy trial for rezatapopt remains on... More
